Most current GHK-Cu content online is cosmetic — wrinkle depth, skin density, anti-aging serum reformulations. That is downstream of the actual story. The original Pickart work in the 1970s identified GHK as a plasma tripeptide whose concentration declines from about 200 ng/mL at age 20 to about 80 ng/mL by age 60, and the first useful clinical signal came not from cosmetics but from chronic non-healing wounds — diabetic foot ulcers, venous leg ulcers and pressure sores that had failed standard care.
This guide pulls the wound-healing literature out from under the anti-aging marketing and assembles it as a research reference. If you are sourcing material for a wound-healing protocol in the UAE, you can buy GHK-Cu UAE — 24h delivery Dubai, Abu Dhabi, Sharjah from REVIVE LAB's Dubai stock.
Mulder et al. (Wound Repair and Regeneration, 1994) remains the single most-cited human wound-healing trial of GHK-Cu. The design was a double-blind, placebo-controlled, multi-center study of topical GHK-Cu gel (then trade-named Iamin) on chronic diabetic neuropathic plantar foot ulcers that had failed standard wound care for at least 8 weeks.
Key features:
The trial is small by modern standards and was never powered for amputation-free survival, but it established proof-of-concept that GHK-Cu accelerates closure in the hardest wound population — chronic diabetic ulcers, where any closure signal at all is unusual.
Where the human data is one good trial, the animal literature is broad and unusually consistent. Across rodent, rabbit and porcine models, GHK-Cu applied topically or injected peri-wound produces faster contraction, more granulation tissue, denser capillary networks and higher tensile strength of the healed scar.
| Model | Wound type | Key result | Reference |
|---|---|---|---|
| Rat (Pickart) | Full-thickness excisional | ~30-40% faster closure vs vehicle; thicker granulation | Pickart 2008 |
| Mouse (Canapp) | Ischemic open wound | Increased angiogenesis, higher VEGF expression | Canapp 2003 |
| Rabbit (Maquart) | Dermal punch biopsy | Decorin and GAG synthesis upregulated | Maquart 1993 |
| Pig (Counts) | Partial-thickness burn | Earlier re-epithelialisation, reduced contracture | Counts 1992 |
| Rat (Simeon) | Standard wound | Decorin mRNA increased ~3-fold | Simeon 1999 |
The cross-species consistency matters because each model isolates a different bottleneck: ischemic mice show GHK-Cu's vascular effect, porcine burns show its re-epithelialisation effect, rabbit dermal punches show its matrix-protein effect. The same molecule moves the needle on all three.
Decorin is a small leucine-rich proteoglycan that organises collagen fibrils, modulates TGF-beta signalling and contributes to scar quality. Maquart's group (Maquart 1993, Simeon 1999) showed that GHK-Cu binding upregulates decorin mRNA and protein in dermal fibroblasts at nanomolar concentrations. Decorin's role is twofold: it improves the tensile strength of new collagen and it limits excessive TGF-beta-driven fibrosis, which is why GHK-Cu-treated wounds tend toward better scar architecture rather than thicker scar.
GHK-Cu increases VEGF expression in keratinocytes and dermal endothelial cells and increases capillary density in the wound bed (Canapp 2003, Pickart 2015). Angiogenesis is the rate-limiting step in chronic non-healing wounds — diabetic ulcers fail to close largely because the wound bed is hypoxic and poorly perfused. Restoring capillary in-growth is mechanistically why GHK-Cu has a signal in diabetic ulcers where most growth factors do not.
The copper(II) ion bound to GHK is not free — it is held in a redox-stable square-planar coordination that gives the molecule SOD-mimetic activity, scavenging superoxide without releasing free copper to drive Fenton chemistry. Pickart 2015 catalogues the antioxidant and TNF-alpha-modulating effects across cell lines.
More recent work (Kang 2009, Pickart 2017) shows GHK-Cu upregulates integrin and p63 expression in basal keratinocytes — markers of the proliferative compartment — suggesting it expands the population of cells capable of re-epithelialising a wound.
The cosmetic GHK-Cu literature (Leyden 2002, Finkley 2005) measures things like wrinkle depth, skin thickness on ultrasound, and self-reported skin appearance over 8-12 weeks of twice-daily topical application on intact aged skin. The endpoints are softer, the population is healthy, and the dose is low.
The wound-healing literature measures hard endpoints on damaged tissue:
Mechanistically the two literatures overlap — both rely on collagen/GAG synthesis and antioxidant effects — but a researcher reading cosmetic papers and inferring wound-healing dosing would underdose. Wound protocols generally use higher concentrations and direct application to the wound bed rather than intact skin.
REVIVE supplies GHK-Cu in 50 mg and 100 mg vials. The wound-healing literature has used a wide range of concentrations:
| Use context | Typical concentration | Notes |
|---|---|---|
| Mulder 1994 topical gel | ~0.4% w/w in hydrogel | Twice-daily under offloading |
| Maquart cell culture | 1-10 nM in fibroblast media | Decorin upregulation range |
| Canapp animal injectable | ~1 mg peri-wound | SC or intradermal |
| Research SC reconstitution | 50 mg vial + 5 mL BAC = 10 mg/mL | Most common research stock |
| Research SC reconstitution | 100 mg vial + 5 mL BAC = 20 mg/mL | Concentrated stock; smaller draw |
For practical reconstitution math, see the GHK-Cu reconstitution guide.
REVIVE LAB stocks GHK-Cu in Dubai and ships across the UAE with full cold-chain logistics. The copper-peptide complex is sensitive to heat, humidity and prolonged transit time — three things the UAE summer guarantees if you order from overseas. Sourcing locally from REVIVE LAB means the vial spends hours, not weeks, in the supply chain.
| Emirate | Delivery window | Cut-off for same-day |
|---|---|---|
| Dubai | Same-day | Order by 2 pm |
| Sharjah | Same-day | Order by 1 pm |
| Ajman | Next-day (24h) | n/a |
| Abu Dhabi | Next-day (24h) | Order by 5 pm |
| Ras Al Khaimah | Next-day (24h) | n/a |
| Fujairah | Next-day (24h) | n/a |
| Umm Al Quwain | Next-day (24h) | n/a |
Lyophilised GHK-Cu is stable at room temperature for the short shipping window, but extended exposure to UAE summer heat (frequently above 40 C in vehicles and warehouses) can degrade the copper coordination and shift the peptide to a less bioactive form. REVIVE's local warehouse means the lyophilised vial never sits in an unrefrigerated international container. Once reconstituted, store at 2-8 C and use within 28 days.
For the wider stocked range and pricing across all peptides REVIVE carries in the UAE, see peptides UAE — full catalogue.
To stay honest with the literature:
This is why we treat GHK-Cu as a strong candidate for wound-healing research protocols rather than as an established clinical product. For comparative discussion of GHK-Cu against the other wound-healing peptides in the REVIVE catalogue, see BPC-157 vs GHK-Cu for wound healing.
GHK-Cu 50 mg and 100 mg vials are in stock UAE at the REVIVE LAB Dubai warehouse. Order today and the vial reaches Dubai or Sharjah the same day, Abu Dhabi and the Northern Emirates next-day, with cold-chain packaging and an HPLC certificate of analysis on every batch. Buy GHK-Cu UAE 24h delivery directly from the product page.